| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.2 | 7e-05 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0003 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0004 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0008 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0009 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.16 | 0.001 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.16 | 0.001 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |